The authors thank D. Dehay (CH Valenciennes) for expert technical assistance, BioCytex Co. for providing reagents, V. Deken (Centre d'Etude et de Recherche en Informatique Me ´dicale, CHRU Lille), and INSERM U795 for their contribution to statistical analysis.
Infectious pulmonary complications in patients treated with anti-TNF-α monoclonal antibodies and soluble TNF receptor
✍ Scribed by Javier Carbone; Javier Perez-Rojas; Elizabeth Sarmiento
- Book ID
- 107542739
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 344 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1523-3847
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Anti-tumor necrosis factor (TNF) therapy used in patients with inflammatory bowel disease (IBD) has been associated with induction of autoantibodies including antinuclear antibodies (ANA), double-strand (ds) DNA antibodies, and the occurrence of lupus-like syndrome (LLS). However, the cl
This study evaluates the plasma levels of tumor necrosis factor-a (TNF-a), interleukin-1p (IL-lp), and soluble IL-2 receptor (slL-2R) in cancer patients infused with radiolabelled murine monoclonal antibodies (MAbs) for the purposes of imaging and dosimetry. Blood samples were collected from 13 pati